Royal Bank of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $210M | Sell |
|
|||||
|
2025
Q2 | $202M | Buy |
|
|||||
|
2025
Q1 | $129M | Sell |
|
|||||
|
2024
Q4 | $206M | Buy |
|
|||||
|
2024
Q3 | $275M | Buy |
|
|||||
|
2024
Q2 | $209M | Buy |
|
|||||
|
2024
Q1 | $133M | Sell |
|
|||||
|
2023
Q4 | $230M | Buy |
|
|||||
|
2023
Q3 | $132M | Buy |
|
|||||
|
2023
Q2 | $110M | Sell |
|
|||||
|
2023
Q1 | $149M | Sell |
|
|||||
|
2022
Q4 | $215M | Sell |
|
|||||
|
2022
Q3 | $223M | Sell |
|
|||||
|
2022
Q2 | $199M | Buy |
|
|||||
|
2022
Q1 | $220M | Buy |
|
|||||
|
2021
Q4 | $176M | Buy |
|
|||||
|
2021
Q3 | $119M | Buy |
|
|||||
|
2021
Q2 | $56.3M | Sell |
|
|||||
|
2021
Q1 | $48.2M | Sell |
|
|||||
|
2020
Q4 | $79.9M | Buy |
|
|||||
|
2020
Q3 | $67.5M | Buy |
|
|||||
|
2020
Q2 | $67.5M | Buy |
|
|||||
|
2020
Q1 | $40.2M | Buy |
|
|||||
|
2019
Q4 | $26.4M | Sell |
|
|||||
|
2019
Q3 | $28.3M | Buy |
|
|||||
|
2019
Q2 | $22.5M | Sell |
|
|||||
|
2019
Q1 | $51.9M | Buy |
|
|||||
|
2018
Q4 | $31.8M | Buy |
|
|||||
|
2018
Q3 | $34.2M | Buy |
|
|||||
|
2018
Q2 | $23.4M | Sell |
|
|||||
|
2018
Q1 | $31.6M | Buy |
|
|||||
|
2017
Q4 | $28.2M | Buy |
|
|||||
|
2017
Q3 | $29.5M | Sell |
|
|||||
|
2017
Q2 | $33.1M | Buy |
|
|||||
|
2017
Q1 | $25.1M | Sell |
|
|||||
|
2016
Q4 | $26.3M | Buy |
|
|||||
|
2016
Q3 | $23.3M | Buy |
|
|||||
|
2016
Q2 | $18.4M | Sell |
|
|||||
|
2016
Q1 | $23M | Sell |
|
|||||
|
2015
Q4 | $36.1M | Buy |
|
|||||
|
2015
Q3 | $24.2M | Sell |
|
|||||
|
2015
Q2 | $36.9M | Sell |
|
|||||
|
2015
Q1 | $32.9M | Sell |
|
|||||
|
2014
Q4 | $37.8M | Buy |
|
|||||
|
2014
Q3 | $30.4M | Buy |
|
|||||
|
2014
Q2 | $10.8M | Sell |
|
|||||
|
2014
Q1 | $23.8M | Sell |
|
|||||
|
2013
Q4 | $27.5M | Buy |
|
|||||
|
2013
Q3 | $28.4M | Buy |
|
|||||
|
2013
Q2 | $13.4M | Buy |
|